277 related articles for article (PubMed ID: 34795117)
1. [Opioid-Induced Constipation in Patients with Cancer Pain].
Aruga E
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
[TBL] [Abstract][Full Text] [Related]
2. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
[TBL] [Abstract][Full Text] [Related]
3. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Pharmacist-Driven Protocol for the Treatment of Opioid-Induced Constipation.
Tryson AR; Hennessey EK; Crannage AJ
J Pharm Pract; 2022 Apr; 35(2):218-222. PubMed ID: 35484871
[TBL] [Abstract][Full Text] [Related]
5. Opioid-induced constipation: a stepwise treatment algorithm feasibility study.
Davies AN; Leach C; Butler C; Patel SD; Shorthose K; Batsari K
BMJ Support Palliat Care; 2023 Dec; 13(e2):e446-e453. PubMed ID: 34348942
[TBL] [Abstract][Full Text] [Related]
6. Opioid-Related Constipation.
Liu JJ; Brenner DM
Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Fernández-Montes A; de Velasco G; Aguín S; Farriols C; Guirado-Risueño M; Jerviz-Guía VG; Baeza-Nadal MV; Chicas-Sett R; Fírvida JL; García-Navalón F; Martín P; Perezagua-Marín C; Rodríguez D; Santamaría J; Saurí T; Cobo M
Curr Treat Options Oncol; 2021 Feb; 22(3):26. PubMed ID: 33635493
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
[TBL] [Abstract][Full Text] [Related]
9. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
[TBL] [Abstract][Full Text] [Related]
10. Evaluating naloxegol for the treatment of opioid-induced constipation.
Daniali M; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
[TBL] [Abstract][Full Text] [Related]
11. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
Rauck RL
Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
[TBL] [Abstract][Full Text] [Related]
12. Naldemedine: A Review in Opioid-Induced Constipation.
Blair HA
Drugs; 2019 Jul; 79(11):1241-1247. PubMed ID: 31267482
[TBL] [Abstract][Full Text] [Related]
13. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
Holzer P
Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
[TBL] [Abstract][Full Text] [Related]
14. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
Gallo P
Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
[TBL] [Abstract][Full Text] [Related]
15. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
[TBL] [Abstract][Full Text] [Related]
16. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
[TBL] [Abstract][Full Text] [Related]
17. Investigational opioid antagonists for treating opioid-induced bowel dysfunction.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Investig Drugs; 2018 Mar; 27(3):235-242. PubMed ID: 29266973
[TBL] [Abstract][Full Text] [Related]
18. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
19. Management of opioid-induced constipation.
Prichard D; Norton C; Bharucha AE
Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
[TBL] [Abstract][Full Text] [Related]
20. Opioid-induced constipation in chronic noncancer pain.
Weber HC
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]